help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 20, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-1451
A more recent version of this article appeared on February 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
93/2/491    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Studen, K. B.
Right arrow Articles by Barkan, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Studen, K. B.
Right arrow Articles by Barkan, A.
Related Collections
Right arrow Neuroendocrinology and Pituitary
Right arrow Endocrine Oncology

Submitted on June 28, 2007
Accepted on November 8, 2007

Assessment of the magnitude of growth hormone (GH) hypersecretion in active acromegaly: reliability of different sampling models

Katica Bajuk Studen and Ariel Barkan*

Division of Metabolism, Endocrinology and Diabetes and Department of Neurosurgery, University of Michigan Medical Center, Ann Arbor, Michigan 48109-5354

* To whom correspondence should be addressed. E-mail: abarkan{at}umich.edu.

Context: The pulsatility of GH secretion in acromegaly poses difficulty in ascertaining true daily GH milieu in patients with this disease. Intensive GH sampling (Q10–20 min for 24h) is not practical in clinical practice.

Objective: To ascertain reliability of abbreviated sampling protocols to reflect true 24h mean GH concentrations in patients with acromegaly.

Design: Analysis of previously-obtained plasma GH profiles

Setting: General Clinical Research Center at the University of Michigan

Patients: A total of 115 GH profiles obtained in 94 patients with active acromegaly.

Intervention: Frequent blood sampling, i.e. Q10–20 min for 24h.

Main Outcome Measure: Concordance of 24h mean GH concentrations derived from Q10–20 min samplings with abbreviated GH sampling schedules. The study was planned after data collection.

Results: All abbreviated schedules of GH sampling correlated well with the true 24h plasma GH means (i.e. Q10–20 min sampling), R = 0.93–0.98; p < 0.0001 for all. In the GH range > 20 µg/L, only 5h and 9h means had R values > 0.9. Single GH concentrations < 1 µg/L had PPV of only 0.29 and those with < 2.5 µg/L had PPV of 0.67 vs. their corresponding 24h mean GH values of the same magnitude.

Conclusions: The intensity of GH sampling in patients with acromegaly may vary depending on the nature of the required information. Investigators and clinicians should be aware of the limitations of the abbreviated GH sampling protocols in acromegaly.


Key words: acromegaly • growth hormone • sampling







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society